ACI Formulations (DHA:ACIFORMULA) Interest Expense: BDT-243 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:ACIFORMULA ACI Formulations PLC DHA:ACIFORMULA
91 GF Score
Price BDT152.70
GF Value BDT150.73
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is ACI Formulations Interest Expense?

ACI Formulations DHA:ACIFORMULA +3.11% 91 Interest Expense is BDT-243 Mil as of Mar. 2026. GuruFocus rates DHA:ACIFORMULA with a GF Score™ of 91/100 and a GF Value™ of BDT150.73 (Fairly Valued). The stock has 4 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. ACI Formulations's interest expense for the three months ended in Mar. 2026 was BDT -67 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was BDT-243 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. ACI Formulations's Operating Income for the three months ended in Mar. 2026 was BDT 145 Mil. ACI Formulations's Interest Expense for the three months ended in Mar. 2026 was BDT -67 Mil. ACI Formulations's Interest Coverage for the quarter that ended in Mar. 2026 was 2.17. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ACI Formulations  (DHA:ACIFORMULA) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ACI Formulations's Interest Expense for the three months ended in Mar. 2026 was BDT-67 Mil. Its Operating Income for the three months ended in Mar. 2026 was BDT145 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was BDT29 Mil.

ACI Formulations's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*144.879/-66.815
=2.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

ACI Formulations Interest Expense Historical Data

* Premium members only.

The historical data trend for ACI Formulations's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ACI Formulations Interest Expense Chart

ACI Formulations Annual Data
Trend Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -129.33 -133.09 -202.86 -209.00 -264.07

ACI Formulations Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -57.23 -54.98 -56.18 -64.61 -66.82
DHA:ACIFORMULA
91GF Score
ACI Formulations PLC DHA:ACIFORMULA
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ACI Formulations Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-243 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of BDT-243 Mil mean?
ACI Formulations (DHA:ACIFORMULA) has a Interest Expense of BDT-243 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on ACI Formulations and its competitors.
Is ACI Formulations' Interest Expense too high?
ACI Formulations' current Interest Expense is BDT-243 Mil. Overall, ACI Formulations has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ACI Formulations' Interest Expense compare to CTVA and CF?
ACI Formulations' Interest Expense of BDT-243 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for an Agriculture company?
A good Interest Expense depends on the Agriculture industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on ACI Formulations and its competitors. ACI Formulations's current Interest Expense is BDT-243 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACI Formulations stock overvalued right now?
Based on GuruFocus' analysis, ACI Formulations (DHA:ACIFORMULA) is currently considered Fairly Valued. The stock's GF Value™ is BDT150.73, compared to a current price of BDT152.70 — trading 1.3% above its estimated fair value. The current Interest Expense is BDT-243 Mil. ACI Formulations' overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For ACI Formulations (DHA:ACIFORMULA), the current Interest Expense is BDT-243 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ACI Formulations (DHA:ACIFORMULA) Overvalued in 2026?

Based on GuruFocus' analysis, ACI Formulations stock appears to be overvalued. The current stock price of BDT152.70 is trading 1.3% above its estimated GF Value™ of BDT150.73. GuruFocus considers ACI Formulations to be Fairly Valued.

Key valuation signals for DHA:ACIFORMULA:

  • Interest Expense: BDT-243 Mil
  • GF Value™: BDT150.73 vs. price of BDT152.70 (1.3% above fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the DHA:ACIFORMULA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ACI Formulations Business Description

Address ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208
ACI Formulations PLC is engaged in the manufacturing and marketing of several agrochemical and consumer products. The company offers a complete range of cost-effective solutions for farmers through formulating and marketing insecticides, herbicides, fungicides, miticides, etc. Its businesses are Pharmaceuticals, Salt, Skincare & Antiseptics, Kitchen Care, Fabric Care, Surface Care, Herbal Care, Lavatory Care, and Others. The group's reportable segments are Crop Care and Public Health (CC & PH), which include manufacturing and selling crop care and public health products; Mosquito coil (M. Coil) includes manufacturing and selling mosquito coil products; Aerosol provides manufacturing and selling aerosol and air freshener products; and Paint covers manufacture and sell paint products.
91GF Score

Get the complete analysis for DHA:ACIFORMULA

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT152.70
Price
BDT150.73
GF Value